ORIGINAL PAPER
Association between the metabolic profile of urolithiasis in children with idiopathic hypercalciuria and the composition of the stone assessed by infrared spectroscopy
1
Department of Pediatrics, Nephrology and Allergology, Military Institute of Medicine – National Research Institute, Warsaw, Poland
2
Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine – National Research Institute, Warsaw, Poland
3
Department of Pediatric Surgery and Pediatric Urology, Centre of Postgraduate Medical Education, Dziekanow Lesny, Poland
Submission date: 2023-04-28
Final revision date: 2023-08-09
Acceptance date: 2023-08-09
Publication date: 2023-12-15
Corresponding author
Małgorzata Placzyńska
Małgorzata Placzyńska, PhD, Department of Pediatrics, Nephrology and Allergology, Military Institute of Medicine – National Research Institute, Szaserów 128, 04-141 Warsaw
Małgorzata Placzyńska, PhD, Department of Pediatrics, Nephrology and Allergology, Military Institute of Medicine – National Research Institute, Szaserów 128, 04-141 Warsaw
Pediatr Pol 2023;98(4):271-277
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Urolithiasis is an increasingly common condition. Each patient after stone passage should have stone analysis performed. Every child with a urinary stone should be given a complete metabolic evaluation, and the stone analysis is an essential component of it. The aim of the study was to establish the relation between the metabolic profile of urolithiasis in children with idiopathic hypercalciuria and the composition of the excreted stone.
Material and methods:
The study included 26 children with urolithiasis (aged 1–17 years) from whom stones were obtained for the analysis. The urine pH and the 24-hour urine excretion of calcium, phosphorus, magnesium and oxalate as well as spot urinalysis including ratio of crystalloids to creatinine from the second voided urine sample of the day were assessed. Urinary stones were analyzed by infrared spectroscopy. The relation between the metabolic data and the stone type was then analyzed, taking into account two types of minerals: stones with a predominance of calcium oxalate dihydrate (weddellite) and calcium oxalate monohydrate (whewellite).
Results:
No correlation was found between the individual serum metabolic parameters of the patient and the composition of excreted stones. Substantially lower urinary excretion of phosphates, oxalate, magnesium and lower urinary pH were found in the group with predominant weddellite stones. A reduced value of each of these 4 variables increased more than sixfold the chance of diagnosing urolithiasis with stone composed of over 60% weddellite.
Conclusions:
The urinary metabolic profile is associated with the composition of renal stones estimated in infrared spectroscopy in children with idiopathic hypercalciuria. The coexistence of several urinary excretion anomalies improves the prediction of the composition of the stones.
Urolithiasis is an increasingly common condition. Each patient after stone passage should have stone analysis performed. Every child with a urinary stone should be given a complete metabolic evaluation, and the stone analysis is an essential component of it. The aim of the study was to establish the relation between the metabolic profile of urolithiasis in children with idiopathic hypercalciuria and the composition of the excreted stone.
Material and methods:
The study included 26 children with urolithiasis (aged 1–17 years) from whom stones were obtained for the analysis. The urine pH and the 24-hour urine excretion of calcium, phosphorus, magnesium and oxalate as well as spot urinalysis including ratio of crystalloids to creatinine from the second voided urine sample of the day were assessed. Urinary stones were analyzed by infrared spectroscopy. The relation between the metabolic data and the stone type was then analyzed, taking into account two types of minerals: stones with a predominance of calcium oxalate dihydrate (weddellite) and calcium oxalate monohydrate (whewellite).
Results:
No correlation was found between the individual serum metabolic parameters of the patient and the composition of excreted stones. Substantially lower urinary excretion of phosphates, oxalate, magnesium and lower urinary pH were found in the group with predominant weddellite stones. A reduced value of each of these 4 variables increased more than sixfold the chance of diagnosing urolithiasis with stone composed of over 60% weddellite.
Conclusions:
The urinary metabolic profile is associated with the composition of renal stones estimated in infrared spectroscopy in children with idiopathic hypercalciuria. The coexistence of several urinary excretion anomalies improves the prediction of the composition of the stones.
REFERENCES (30)
1.
Routh JC, Graham DA, Nelson CP. Epidemiological trends in pediatric urolithiasis at United States freestanding pediatric hospitals. J Urol 2010; 184: 1100-1104.
2.
Ward JB, Feinstein L, Pierce C, et al. Pediatric urinary stone disease in the United States: the urologic diseases in America Project. Urology 2019; 129: 180-187.
3.
Türk C, Petřík A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 2016; 69: 468-474.
4.
Hoppe B, Kemper MJ. Diagnostic examination of the child with urolithiasis or nephrocalcinosis. Pediatr Nephrol 2010; 25: 403-413.
5.
Spivacow FR, Del Valle EE, Lores E, et al. Kidney stones: composition, frequency and relation to metabolic diagnosis. Medicina (B Aires) 2016; 76: 343-348.
6.
Cloutier J, Villa L, Traxer O, Daudon M. Kidney stone analysis: “Give me your stone, I will tell you who you are!”. World J Urol 2015; 33: 157-169.
7.
Anderson RA. A complementary approach to urolithiasis prevention. World J Urol 2002; 20: 294-301.
8.
Hesse A, Tiselius HG, Jahnen A. Urinary stones. General aspects. In: Hesse A, Tiselius HG, Jahnen A. Urinary Stones. Diagnosis, Treatment and Prevention of Recurrence. Karger, Basel 2002; 11-43.
9.
Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet 2001; 358: 651-656.
10.
Daudon M, Jungers P. Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Nephron Physiol 2004; 98: 31-36.
11.
Daudon M, Jungers P, Bazin D. Stone morphology: implication for pathogenesis. In: Evan AP, Lingeman JE, McAteer JA et al. Renal stone disease 2. American Institute of Physics conference proceedings. Melville, New York 2008; 1049: 199-215.
12.
Maurice-Estepa L, Levillain P, Lacour B, et al. Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. Scand J Urol Nephrol 1999; 33: 299-305.
13.
Spivacow FR, Negri AL, del Valle EE, et al. Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 2008; 23: 1129-1133.
14.
Hoppe B, Leumann E, von Unruh G, et al. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci 2003; 8: 437-443.
15.
Demoulin N, Aydin S, Gillion V, et al. Pathophysiology and management of hyperoxaluria and oxalate nephropathy: a review. Am J Kidney Dis 2022; 79: 717-727.
16.
Baştuğ F, Düşünsel R. Pediatric urolithiasis: causative factors, diagnosis and medical management. Nat Rev Urol 2012; 9: 138-146.
18.
Schwartz BF, Bruce J, Leslie S, et al. Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol 2001; 15: 233-235.
19.
Eisner BH, Sheth S, Dretler SP, et al. High dietary magnesium intake decreases hyperoxaluria in patients with nephrolithiasis. Urology 2012; 80: 780-783.
20.
Tavasoli S, Taheri M, Taheri F, et al. Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients. Int Urol Nephrol 2019; 51: 279-284.
21.
Bonny O, Rubin A, Huang CL, et al. Mechanism of urinary calcium regulation by urinary magnesium and pH. J Am Soc Nephrol 2008; 19:1530-1537.
22.
Prié D, Ravery V, Boccon-Gibod L, et al. Frequency of renal phosphate leak among patients with calcium nephrolithiasis. Kidney Int 2001; 60: 272-276.
23.
Negri AL, Spivacow R, Del Valle E, et al. Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urol Res 2003; 31: 378-381.
24.
Kim YJ, Kim TH, Yun SJ, et al. Renal phosphate control as a reliable predictive factor of stone recurrence. J Urol 2009; 181: 2566-2572.
25.
Levi M, Breusegem S. Renal phosphate-transporter regulatory proteins and nephrolithiasis. N Engl J Med 2008; 359: 1171-1173.
26.
Bushinsky DA. Nephrolithiasis: site of the initial solid phase. J Clin Invest 2003; 111: 602-605.
27.
Ratkalkar VN, Kleinman JG. Mechanisms of stone formation. Clin Rev Bone Miner Metab 2011; 9: 187-197.
28.
Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol 2010; 23: 165-169.
29.
Turudic D, Batinic D, Golubic AT, et al. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios. Eur J Pediatr 2016; 175: 1959-1965.
30.
Wang X, Wang M, Ruan J, et al. Identification of urine biomarkers for calcium-oxalate urolithiasis in adults based on UPLC-Q-TOF/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2019; 1124: 290-297.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
